MASSDEVICE ON CALL — Masimo’s (NSDQ:MASI) Patient Safety Movement Foundation touted a major win this week as Medicare regulators updated their guidance on monitoring for patients on IV opioids.
The Centers for Medicare & Medicaid Services issued new guidance on hospital medication administration, including "the need for post-operative monitoring of patients receiving IV opioid medications, regardless of where they are in the hospital."
CMS included a nod to the PSMF, citing the foundations recommendations that all patients receiving IV opioids get extra monitoring.
"PSMF recommends all patients receiving IV opioids have continuous measure-through motion and low perfusion pulse oximetry, and that patients on supplemental oxygen also have continuous respiration rate monitoring," according to the CMS update. "It also calls for the monitoring system to be linked with a notification system to clinical staff who can respond immediately. It calls for an escalation protocol so that if a staff person does not acknowledge the alert in 60 seconds a second person will be notified."
The PSMF was founded through the Masimo Foundation for Ethics Innovation & Competition in Healthcare. The agency has been holding annual conferences to bring together device makers and other healthcare stakeholders in the interest of eliminating preventable hospital injuries and deaths.
Medtronic pacemaker sales poised to rise
Medtronic (NYSE:MDT) is poised for a boost in its pacemaker sales following clinical trial findings that its sophisticating pacing algorithms may help curb persistent atrial fibrillation.
Read more
A wearable malaria-detector
This year’s MIT$100K competition winner took home about $145,000 in prize money for a wrist-worn malaria detection system.
Read more
Touch Bionics’ prosthetics adjust automatically with environmental cues
Touch Bionics system of Bluetooth-enabled "Grip Chip" stickers send signals to a user’s i-limb prosthetic hand to automatically shift fingers into useful positions.
Read more
Sens. Ayotte, Toomey reiterate commitment to device tax repeal
Sen. Kelly Ayotte (R-N.H.) and Pat Toomey (R-Pa.) introduced a new amendment to repeal the 2.3% medical device tax.
Read more
